August 26, 2008
Shire's Vyvanse, an attention deficit and hyperactivity disorder drug, has received approval for adults. Vyvanse is now available in three additional dosage strengths.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.